The Toronto Stock Exchange reports that Apotex Health Corp. will be listed at 5:01 p.m. on June 15, 2026, for trading at the open on June 16, 2026. According to the TSX, there will be 228,499,020 common shares of the company issued and outstanding, and 27,141,089 shares reserved for issuance. The shares will trade under the symbol APTX, in Canadian dollars and with Cusip No. 03772D 10 1.

The TSX notes that the shares commenced trading on an if, as and when-issued basis on Wednesday, June 10, 2026. Subject to the offering (as described below) closing as scheduled before the on June 16, 2026, trading on an if, as and when-issued basis will conclude at the close on June 15, 2026. As stated in Apotex Health's supplemented PREP prospectus dated June 10, 2026, the offering will comprise: (i) a treasury offering by the company of 35,416,666 shares; and (ii) a secondary offering by the selling shareholders of 18,750,004 shares, at an offering price of $24 per share, for total gross proceeds of $1,300,000,080, of which $849,999,984 will be received by the company. In addition, the selling shareholders have granted the underwriters an overallotment option to purchase up to an additional 8,125,000 shares at the offering price.

The TSX reports that Apotex Health is a Canadian-based global health company with a broad portfolio of generic, biosimilar and branded pharmaceuticals, as well as branded consumer health and wellness products. The company's transfer agent and registrar is Odyssey Trust Company at its principal office in Toronto, and its fiscal year-end is March 31. The temporary market-maker is TD Securities Inc.

According to the TSX, the company anticipates paying quarterly cash dividends of approximately five cents per share, representing an initial annual yield of approximately 0.8 per cent based on the offering price. The first dividend that would be payable would be the dividend for the period beginning on the closing date to June 30, 2026, and for the first full quarter ending Sept. 30, 2026, is expected to be paid on or about Sept. 30, 2026, to shareholders of record on Sept. 15, 2026, and is estimated to be six cents per share (one cent in respect of the period from and including the closing date to June 30, 2026, and five cents in respect of the full first quarter ending Sept. 30, 2026). The amount and timing of the payment of any dividends are not guaranteed and are subject to the discretion of the company's board.

For more information, see the TSX bulletins dated June 8, 2026, and June 10, 2026.